Philadelphia chromosome-positive acute lymphoblastic leukemia secondary to chemoradiotherapy for Ewing sarcoma. Report of two cases and concise review of the literature

Am J Hematol. 2005 Jan;78(1):74-8. doi: 10.1002/ajh.20251.

Abstract

Survivors of childhood solid tumors including Ewing sarcoma (ES) have an increased risk of secondary malignant neoplasms (SMNs) as a consequence of exposure to chemotherapy and/or radiation (see: Bhatia S, Sklar C. Nat Rev Cancer 2002;2:124-132). The most common hematologic SMNs are myelodysplasia (MDS) and acute myelogenous leukemia (AML). Acute lymphoblastic leukemia (ALL) is uncommon in this patient population, and Philadelphia chromosome positive (Ph+) ALL in particular, is rare. We report herein two cases of young adult patients who were both diagnosed with Ph+ ALL 19 years after successful treatment for ES with combined modality therapy. A review of the relevant literature follows the case reports.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / radiotherapy*
  • Combined Modality Therapy / adverse effects
  • Humans
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / etiology*
  • Radiation Injuries / complications*
  • Sarcoma, Ewing / drug therapy*
  • Sarcoma, Ewing / radiotherapy*
  • Time Factors

Substances

  • Antineoplastic Agents